Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Identification of Novel Therapeutic Biomarkers in Rheumatoid Arthritis: A Combined Bioinformatics and Integrated Multi-Omics Approach

19 Mar 2025

Abstract excerpt

Rheumatoid arthritis (RA) is a multifaceted autoimmune disease that is marked by a complex molecular profile influenced by an array of factors, including genetic, epigenetic, and environmental elements. Despite significant advancements in research, the precise etiology of RA remains elusive, presenting challenges in developing innovative therapeutic markers. This study takes an integrated multi-omics approach to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Lymphocytic Leukemia Research
Share to Hepatitis C virus research
Share to Rheumatoid Arthritis Research and Therapies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40141401
DOI: 10.3390/ijms26062757

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Identification of Novel Therapeutic Biomarkers in Rheumatoid Arthritis: A Combined Bioinformatics and Integrated Multi-Omics ApproachPMID 40141401Read ↗

-Omic Approaches and Treatment Response in Rheumatoid ArthritisSemantic proximity Read ↗

A large-scale multi-omics polygenic risk score analysis identified candidate risk locus associated with rheumatoid arthritis.Semantic proximity Read ↗

Super-omics and PCAS reveal tumor-like molecular landscape of rheumatoid arthritisSemantic proximity Read ↗

Rheumatoid Arthritis: Biomarkers and the Latest BreakthroughsSemantic proximity Read ↗

Prediction of New Risk Genes and Potential Drugs for Rheumatoid Arthritis from Multiomics Data.Semantic proximity Read ↗

Novel loci and multi-omics risk models for rheumatoid arthritis through a million-participant genome-wide association meta-analysisSemantic proximity Read ↗

Identification of PSMB9 and CXCL13 as Immune-related Diagnostic Markers for Rheumatoid Arthritis by Machine LearningSemantic proximity Read ↗

Integrative Multiomics Network Analysis of Genetic Risk Factors to Infer Biomarkers and Therapeutic Targets for Rheumatoid ArthritisSemantic proximity Read ↗

Identifying therapeutic targets for rheumatoid arthritis by genomics-driven integrative approachesSemantic proximity Read ↗

Rheumatoid arthritis: pathogenesis and therapeutic advancesSemantic proximity Read ↗

Linking of genetic risk variants to disease-specific gene expression via multi-omics studies in rheumatoid arthritis.Semantic proximity Read ↗

Genetics of rheumatoid arthritis contributes to biology and drug discovery.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.